Validation of the PLASMIC score for predicting ADAMTS13 activity <10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada
Chris Wynick, J. Britto, Daniel Sawler, Arabesque Parker, Mohammad Karkhaneh, M. Dawn Goodyear, Haowei Sun
Topics & Concepts
ADAMTS13MedicineThrombotic thrombocytopenic purpuraInternal medicinePopulationPredictive value of testsProthrombin timeGastroenterologyPlateletEnvironmental healthComplement system in diseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaCystic Fibrosis Research Advances